Single-use Bioprocessing Probes and Sensors Market is segmented By Product Type(P.H. Sensors, Oxygen Sensors, Pressure Sensors, Temperature sensors, Conductivity sensors, Flow meters and sensors & Others), By Workflow (Upstream, Downstream), By End-User(Biopharmaceutical Manufacturers, Pharmaceutical Industry And Academic Research & Others), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2024-2031.
Single-use Bioprocessing Probes and Sensors Market is predicted to reach at a high CAGR of 13.9% during the forecast period (2024-2031).
Single-use Bioprocessing Probes and Sensors Market
|
Metrics |
Details |
|
Market CAGR |
13.9% |
|
Segments Covered |
By Product Type, By Workflow, By End-User, and By Region |
|
Report Insights Covered |
Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights. |
|
Fastest Growing Region |
Asia Pacific |
|
Largest Market Share |
North America |
Market Dynamics
The major factors driving the growth of this market are the use of single-use technology to meet the drug shortage worldwide, increase in the number of diseases and geriatric population with increase in conditions like diabetes, obesity etc. is expected to drive the market.
The use of single-use bioprocessing probes and sensors is expected to drive the market growth
The availability of improved bioprocess and easy monitoring process of bio-processing creates an increased demand for bioprocessing units in biotechnology and the pharmaceutical sector. Single-use bioprocessing sensors are cost-effective and provide minimum contamination rates. Deployment of single-use bioprocessing helps increase productivity due to the reduced complexity of automation and manufacturing costs, as the need for sterilization is eliminated. In addition, it allows full-scale manufacturing as the cost of water and chemicals is lower for single-use systems than conventional stainless-steel hardware systems.
An increase in the number of diseases is expected to drive the market
There has been an increase in the number of diseases in the biopharmaceutical sector, such as cancer, arthritis, diabetes etc. And the market is expected to be helpful for their treatment, is expected to see an increase in demand. Single-use bioprocessing systems are designed for faster manufacturing and to save floor space. This reduces the time staff spends on preparation, set-up, validation and documentation. Furthermore, single-use bioreactors offer flexibility, initiating the trend of multi-drug facilities fulfilling the demand of production of different drugs under the same roof.
Environmental concerns is expected to hinder the market
Safe disposal and technical issues may hamper the market growth. Environmental impact can be assessed in several ways: e.g., disposal methods for liquid and solid waste, the carbon footprint of an overall process, and complete life-cycle analysis for materials and components. However, the environmental impact of single-use technologies has been a significant focus of attention only in recent years. This evolving interest has been driven by many factors, including concerns over environmental change, emissions, and energy supplies; rapidly increasing costs and restrictions on waste disposal; greater recognition of the role of disposables in bioprocessing; and availability of a broader range of disposable options. However, developing new bioprocessing sensors for bioprocess monitoring is expected to probably create new opportunities in the single-use bioprocessing probes and sensors market.
COVID-19 Impact Analysis
The COVID-19 pandemic has impacted different sectors globally and also has a notable impact on the market. It has affected production and demand by creating supply chain and market disruption and its financial impact on firms and financial markets. Biopharmaceutical innovators are at the forefront of the human response to the coronavirus pandemic. A significant number of major biotech firms are in the midst of a race to investigate the Sars-Cov-2 genome and prepare a viable vaccine for the same. Compared to the speed of response to SARS/MERs, the biotech entities are investigating SARs-Cov-2 at an unprecedented rate, and a considerable amount of funds are being put into the R&D. Thus, the COVID-19 pandemic has affected the market. However, the situation is expected to improve gradually in the forecast period.
Segment Analysis
pH sensors held the largest share in the market
A pH sensor is one of the essential tools that's typically used for water measurements. This type of sensor can measure the amount of alkalinity and acidity in water and other solutions. It is attributed to high product penetration as well as usage rate. Technological advancements in this sensor type, such as the development of pH sensors with in-built temperature sensors, are expected to drive the segment.
Upstream processing dominated the market
The adoption of single-use bioreactors and media bags by bio manufacturers in the upstream manufacturing process has significantly increased the usage of sensors in this segment. The upstream part of a bioprocess refers to the initial stage in which microbes/cells are grown, e.g., bacterial or mammalian cell lines in bioreactors. Upstream processing involves all the steps related to inoculum development: Media Preparation, Cell Culture and Cell Separation & Harvest. When the cells have reached the desired density, they are harvested and moved to the downstream section of the bioprocess. In an upstream process, CPPs that are generally monitored include temperature, Dissolved Oxygen (D.O.), and pH. In addition, other factors such as culture viability, viable-cell density, nutrient levels, specific growth rate, and other measurable parameters are considered as CPPs. On the other hand, although single-use technologies have gained significant ground in biomanufacturing, the biggest challenges still lie in separation and purification.
Biopharmaceuticals Manufacturers accounted for the largest share in the market
Constant new product developments and accelerated adoption of disposables among contract service providers and in-house bio manufacturers to meet the growing global demand for biopharmaceuticals efficiently. Increasing diseases such as cancer, arthritis, diabetes etc., are among the significant factors fueling the segment growth.
North America is expected to see growth in the market in the forecast
Owing to its technological developments and advancements. Presence of major pharmaceutical and biotechnology industries in this region. US-based biopharmaceutical company Emergent BioSolutions extended its partnership with vendor ABEC to develop a dual plant in Maryland. The company also developed a dual-purpose single-use system at its Baltimore, Maryland, for large-scale microbial fermentation and mammalian cell culture. Finally, Merck recently unveiled three novels single-use bioprocessing products, which are expected to make bioprocessing safer and more efficient than the conventional methods.
Geographical Analysis
Measurements such as pressure, temperature, conductivity, and U.V. absorbance for in-line analysis in single-use formats have been used in biopharmaceutical development and manufacturing for many years. The availability of single-use sensors is necessary to drive the implementation of single-use technology from development through to GMP manufacturing.
Competitive Landscape
The single-use bioprocessing probes and sensors market players develop new products with improved technical intricacies to boost the market rate. Some of the key players in this market are Pfizer, Wego Pharmaceuticals, Amgen, Abbvie, Parket Hannifin Corporation, Hamilton Company, Thermo Fisher Scientific, Inc., Sartorius Stedim Biotech S.A, Honeywell International, Inc, Eppendorf AG, G.E. Healthcare, Broadley-James, Shenzhen Tangreat Technology Co., Ltd. Corporation, Tespro Technology Co., Ltd. and Polestar Technologies, Inc.
Single-use Bioprocessing Probes and Sensors Market Key Companies to Watch
Sartorius Stedim Biotech S.A
Overview: Sartorius Stedim Biotech is a leading partner in the biopharma industry. Our solutions are supporting our customers to produce drugs safely, timely and economically. The key product categories of our company are cell cultivation, fermentation, filtration, purification, and fluid management. Sartorius Stedim Biotech has a worldwide presence, with manufacturing, sales and R&D sites in more than 20 countries in Europe, North America and Asia. Focussing on single-use technologies and added-value services to meet the rapidly changing technology requirements of the industry it serves.
Product Portfolio: The Company offers cell cultivation, fermentation, filtration, purification and fluid management.
Key Development: Sartorius offers a wide variety of single-use bioreactors ideal for mammalian cell culture, demanding high cell-density or microcarrier-based processes.